AFT to develop birthmark medicine

Sep 1, 2022 | Latest News

1.9.22 AFT Pharmaceuticals has reached agreement with Massey Ventures, the commercialisation company of Massey University, and the Gillies McIndoe Research Institute, to license intellectual property to allow the development of a topical treatment for strawberry birthmarks (infantile haemangiomas) in children. The agreement covers the intellectual property emerging from Massey Ventures and Gillies McIndoe research that […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options